Fgl2 regulates FcγRIIB+CD8+ T cell responses during infection
JCI Insight · 08.04.2025 · 10 (7)
DOI: 10.1172/jci.insight.186259 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, online erschienen am 08.04.2025. Verfasst von Anna B Morris und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Emory Transplant Center and. Hauptthemen laut MEDLINE: Receptors, IgG, CD8-Positive T-Lymphocytes, COVID-19. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
While the inhibitory receptor FcγRIIB has been shown to be upregulated on activated CD8 + T cells in both mice and humans, its effect on T cell fate during infection has not been fully elucidated. We identified an increase in FcγRIIB-expressing CD8 + T cells in patients with COVID-19 relative to healthy controls as well as in mouse models of viral infection. Despite its well-known role as an Fc receptor, FcγRIIB also ligates the immunosuppressive cytokine Fgl2, resulting in CD8 + T cell apoptosis. Both chronic LCMV infection in mice and COVID-19 in humans resulted in a significant increase in plasma Fgl2. Transfer of CD8 + T cells into a Fgl2-replete, but not Fgl2-devoid, environment resulted in elimination of FcγRIIB + , but not FcγRIIB – , CD8 + T cells. Similarly, plasma Fgl2 was directly proportional to CD8 + T cell lymphopenia in patients with COVID-19. RNA-Seq analysis demonstrated that Fgl2 was produced by murine virus–specific CD8 + T cells, with an increase in Fgl2 in CD8 + T cells elicited during chronic versus acute viral infection. Fgl2 was also upregulated in CD8 + T cells from patients with COVID-19 versus healthy controls. In summary, CD8 + T cell production of Fgl2 during viral infection underpinned an FcγRIIB-mediated loss of CD8 + T cell immunity in both mice and humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery and Emory Transplant Center and.
- Department of Medicine, Division of Infectious Diseases, Emory University, Atlanta, Georgia, USA.
- Department of Medicine, Division of Infectious Diseases, University of California, San Francisco, California, USA.
- Department of Microbiology and Immunology and.
- Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA.
Förderung
- NIAID NIH HHS
- NIH HHS
- NCI NIH HHS
- NIAID
Zitieren
APA
Morris, A. B., Adelman, M. W., Bennion, K. B., Martinez, C. D., McCook, K. M., Woodworth, M. H., Langelier, C. R., Rouphael, N., Scharer, C. D., Maier, C. L., Kraft, C. S., & Ford, M. L. (2025). Fgl2 regulates FcγRIIB+CD8+ T cell responses during infection. JCI Insight, 10(7). https://doi.org/10.1172/jci.insight.186259
Vancouver
Morris AB, Adelman MW, Bennion KB, Martinez CD, McCook KM, Woodworth MH, et al. Fgl2 regulates FcγRIIB+CD8+ T cell responses during infection. JCI Insight. 2025;10(7). doi:10.1172/jci.insight.186259
BibTeX
@article{Morris2025,
author = {Morris, Anna B and Adelman, Max W and Bennion, Kelsey B and Martinez, Catherine D and McCook, Kem-Maria and Woodworth, Michael H and Langelier, Charles R and Rouphael, Nadine and Scharer, Christopher D and Maier, Cheryl L and Kraft, Colleen S and Ford, Mandy L},
title = {Fgl2 regulates FcγRIIB+CD8+ T cell responses during infection},
journal = {JCI Insight},
year = {2025},
volume = {10},
number = {7},
doi = {10.1172/jci.insight.186259}
}
EUVIMED